A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiation Therapy vs Trans-oral Robotic Surgery (ORATOR)
The historical standard treatment for early-stage squamous cell carcinoma of the oropharynx
is radiation therapy. Some patients require chemotherapy with the radiation, and some
patients require surgery if the tumour or lymph nodes have not responded after radiation.
This study will compare radiation therapy with a new surgical treatment called transoral
robotic surgery (TORS). TORS is a new surgical approach using a robot to assist the surgeon
in removing the tumour, potentially with fewer side effects than older surgical techniques.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society